Are randomized controlled trials necessary to establish the value of implementing pharmacogenomics in the clinic?

類似資料

• PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID‐19
  著者:: Huddart, Rachel, 等
  出版事項: (2020)
• Pharmacogenomics Clinical Annotation Tool (PharmCAT)
  著者:: Sangkuhl, Katrin, 等
  出版事項: (2019)
• PharmGKB: A worldwide resource for pharmacogenomic information
  著者:: Barbarino, Julia M., 等
  出版事項: (2018)
• From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource
  著者:: McDonagh, Ellen M, 等
  出版事項: (2011)
• Prediction of CYP2D6 phenotype from genotype across world populations
  著者:: Gaedigk, Andrea, 等
  出版事項: (2017)